Loading chat...
RI H7424
Bill
Status
1/30/2026
Primary Sponsor
Joseph Solomon
Click for details
AI Summary
-
Expands collaborative pharmacy practice agreements to allow licensed pharmacists to partner with any healthcare "providers" who have prescribing privileges, not just physicians
-
Eliminates the six-member "collaborative practice committee" that previously advised the director on regulatory issues, consisting of appointees from the Board of Pharmacy and Board of Medical Licensure
-
Removes the approval/denial process requirement, allowing parties to begin operating under collaborative practice agreements once all documentation is complete
-
Broadens the definition of "limited-function test" to include all CLIA-waived tests, rather than only blood glucose, hemoglobin A1c, and cholesterol tests
-
Effective date: July 1, 2026
Legislative Description
Expands the existing law regarding collaborative practice agreements between pharmacists and physicians to allow other healthcare providers to enter into such agreements and removes the definition of “collaborative practice committee.”
Businesses And Professions
Last Action
Committee recommended measure be held for further study
3/3/2026